Piscataway, NJ, July 21, 2023– Camber Pharmaceuticals is pleased to announce the addition of Posaconazole Delayed-Release Tablets to its current portfolio.
Posaconazole Delayed-Release Tablets are indicated for the prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised.
Posaconazole Delayed-Release 100 mg Tablets are available in a 60-count bottle.
To find out more about Posaconazole Delayed-Release Tablets please visit www.camberpharma.com
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected]
